SIBN (SI-BONE Inc) Return on Sales by Gross Profit

SIBN (SI-BONE Medical) - company brandmark

SI-BONE, Inc. (SIBN) possesses strong pricing power due to the uniqueness of its iFuse systems and inelastic demand within the orthopedic sector. The gross margin history illustrates cost efficiency, where the parameter value equals 79.40. However, it is critical for management to maintain platform expansion rates, while production must address waste utilization and energy consumption issues in accordance with ESG environmental standards.

SI-BONE, Inc. (SIBN): Gross Margin from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for SI-BONE, Inc. (SIBN)

- stock quotes and analyst forecast:
- business market valuation indicators:
Fundamental valuation:SIBN SI-BONE Inc
Finished products of SI-BONE Medical

Gross margin serves as a critical filter for investment reliability, measuring the portion of revenue remaining after direct production costs to evaluate the efficiency of the operating model. Gross margin analysis confirms the resilience of SI-BONE, Inc., where the expansion of the surgical systems market generates sufficient cash flow to cover expansion costs and maintain the issuer's stable financial condition.

Main competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Profitability CooperCompanies COO|Gross Margin Invisalign ALGN|GMED - Gross Profitability|TMDX: Gross Profitability|ATEC (Alphatec Holdings, Inc.) - Return on Gross Profit|Artivion, Inc. - Gross Profit Rate|ENOV (Enovis Inc.) - Gross Margin|Gross Profit Margin Integra LifeSciences Corp IART|Gross Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Gross Sales Margin|IRADIMED Inc. - Return on Gross Profit|Gross Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Gross Margin|Return on Sales by Gross Profit AxoGen Inc AXGN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO